Comparison Between SGLT2 Inhibitors and Pioglitazone as Additions to Insulin Therapy in Type 2 Diabetes: A Systematic Review With an Indirect Comparison Meta-Analysis
Journal of Diabetes Investigation - Australia
doi 10.1111/jdi.12787
Full Text
Open PDFAbstract
Available in full text
Date
January 8, 2018
Authors
Publisher
Wiley